Next generation sequencing analysis of exosomal microRNAs: Fusobacterium nucleatum regulates expression profiling of exosomal microRNAs in human colorectal cancer cells
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Colon cancer is one of the most common malignant tumors, but there are still a few validated biomarkers of coloncancer. Exosome-mediated microRNAs (miRNAs) have been recognized as potential biomarkers in cancers, andmiRNAs can regulate a variety of genes. Recently, Fusobacterium nucleatum was discovered in the tissues of humancolon cancer patients. Its role in colon cancer was highlighted. F. nucleatum may contribute to the progression ofcolon cancer through the mechanism of exosome-mediated miRNAs transfer. However, the exosomal miRNAsregulation mechanism by F. nucleatum in colon cancer is not well known. Thus, we performed next-generationsequencing to investigate the overall pattern of exosomal miRNAs expression in the colon cancer cell culturesupernatant. We have confirmed the alterations of various exosomal miRNAs. In addition, to investigate the functionof exosomal miRNAs, a Kyoto Encyclopedia of Genes and Genomes analysis was performed on the target genesof changed miRNAs. Potential target genes were associated with a variety of signaling pathways, and one of thesepathways was related to colorectal cancer. These findings suggested that F. nucleatum can alter exosomal miRNAsreleased from colorectal cancer cells. Furthermore, exosomal miRNAs altered by F. nucleatum could be potentialbiomarkers for the diagnosis and therapy of colon cancer.
Abstract
Colon cancer is one of the most common malignant tumors, but there are still a few validated biomarkers of coloncancer. Exosome-mediated microRNAs (miRNAs) have been recognized as potential biomarkers in cancers, andmiRNAs can regulate a variety of genes. Recently, Fusobacterium nucleatum was discovered in the tissues of humancolon cancer patients. Its role in colon cancer was highlighted. F. nucleatum may contribute to the progression ofcolon cancer through the mechanism of exosome-mediated miRNAs transfer. However, the exosomal miRNAsregulation mechanism by F. nucleatum in colon cancer is not well known. Thus, we performed next-generationsequencing to investigate the overall pattern of exosomal miRNAs expression in the colon cancer cell culturesupernatant. We have confirmed the alterations of various exosomal miRNAs. In addition, to investigate the functionof exosomal miRNAs, a Kyoto Encyclopedia of Genes and Genomes analysis was performed on the target genesof changed miRNAs. Potential target genes were associated with a variety of signaling pathways, and one of thesepathways was related to colorectal cancer. These findings suggested that F. nucleatum can alter exosomal miRNAsreleased from colorectal cancer cells. Furthermore, exosomal miRNAs altered by F. nucleatum could be potentialbiomarkers for the diagnosis and therapy of colon cancer.
참고문헌 (34)
- Junting Ma, "PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation", Theranostics, 8(11), pp.3022~3037 (2018), Ivyspring International Publisher[DOI]
- Joseph P. Zackular, "Manipulation of the Gut Microbiota Reveals Role in Colon Tumorigenesis", mSphere, 1(1), pp.:e00001-15~ (2016), American Society for Microbiology[DOI]
- Chun-Hui Sun, "The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management", Chronic Diseases and Translational Medicine, 5(3), pp.178~187 (2019), Elsevier BV[DOI]
- Zhenhua Yang, "Fusobacterium nucleatum-positive colorectal cancer", Oncol Lett, 18, pp.975~982 (2019), Spandidos Publications[DOI]
- xuebing yan, "Clinical significance of Fusobacterium nucleatum , epithelial-mesenchymal transition, and cancer stem cell markers in stage III", IV colorectal cancer patients, 2017, pp.10, 5031~5046[DOI]
- Laura Bracci, "The role of exosomes in colorectal cancer disease progression and response to therapy", Cytokine & Growth Factor Reviews, 51, pp.84~91 (2020), Elsevier BV[DOI]
- A Michael, "Exosomes from human saliva as a source of microRNA biomarkers", Oral Diseases, 16(1), pp.34~38 (2010), Wiley[DOI]
- Douglas D. Taylor, "MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer", Gynecologic Oncology, 110(1), pp.13~21 (2008), Elsevier BV[DOI]
- Marie Lafitte, "Roles of exosomes in metastatic colorectal cancer", American Journal of Physiology-Cell Physiology, 317(5), pp.C869~C880 (2019), American Physiological Society[DOI]
- Yongwei Xiao, "Exosomes as potential sources of biomarkers in colorectal cancer", Cancer Letters, 476, pp.13~22 (2020), Elsevier BV[DOI]
- Noah I. Hornick, "Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML", Scientific Reports, 5(1), pp.11295~ (2015), Springer Science and Business Media LLC[DOI]
- Gabriella Guelfi, "Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research", Scientific Reports, 8(1), pp.7111~ (2018), Springer Science and Business Media LLC[DOI]
- J. R. Chevillet, "Quantitative and stoichiometric analysis of the microRNA content of exosomes", Proceedings of the National Academy of Sciences, 111(41), pp.14888~14893 (2014), Proceedings of the National Academy of Sciences[DOI]
- Stephen J. O'Brien, "The role of the miR-200 family in epithelial-mesenchymal transition in colorectal cancer: a systematic review", International Journal of Cancer, 142(12), pp.2501~2511 (2018), Wiley[DOI]
- Piroon Jenjaroenpun, "Characterization of RNA in exosomes secreted by human breast cancer cell lines using next-generation sequencing", PeerJ, 1, pp.e201~ (2013), PeerJ[DOI]
- Liling Zheng, "MiR-26a-5p regulates cardiac fibroblasts collagen expression by targeting ULK1", Scientific Reports, 8(1), pp.2104~ (2018), Springer Science and Business Media LLC[DOI]
- Chao Liu, "miR-324-3p suppresses migration and invasion by targeting WNT2B in nasopharyngeal carcinoma", Cancer Cell International, 17(1), pp.2~ (2017), Springer Science and Business Media LLC[DOI]
- Yunjie He, "miR-149 in Human Cancer: A Systemic Review", Journal of Cancer, 9(2), pp.375~388 (2018), Ivyspring International Publisher[DOI]
- Sheedy P, "The fundamental role of miR-10b in metastatic cancer", Am J Cancer Res, 8, pp.1674~1688 (2018)
- Alejandra Sandoval-Bórquez, "MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer", Clinical Epigenetics, 9(1), pp.114~ (2017), Springer Science and Business Media LLC[DOI]
- Zhengliang Zhang, "miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2", Biomedicine & Pharmacotherapy, 96, pp.1341~1348 (2017), Elsevier BV[DOI]
- CHANG ZHOU, "miR-339-3p inhibits proliferation and metastasis of colorectal cancer", Oncology Letters, 10(5), pp.2842~2848 (2015), Spandidos Publications[DOI]
- Zi‐Ming Huang, "MicroRNA‐26a‐5p inhibits breast cancer cell growth by suppressing RNF6 expression", The Kaohsiung Journal of Medical Sciences, 35, pp.467~473 (2019), Wiley[DOI]
- Han-qun Zhang, "The expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance", OncoTargets and Therapy, 10, pp.4935~4943 (2017), Informa UK Limited[DOI]
- Carlotta Pucci, "Innovative approaches for cancer treatment: current perspectives and new challenges", Ecancermedicalscience, 13, pp.961~ (2019), Ecancer Global Foundation[DOI]
- Xinfeng Yu, "CXCL12", CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p, 2019, pp.38(1), 32~[DOI]
- Sheng Zhang, "Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer", Journal of Experimental & Clinical Cancer Research, 38(1), pp.14~ (2019), Springer Science and Business Media LLC[DOI]
- Chen B, "Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis", Open Biol, 9, pp.180212~ (2019)
- Simona Rossi, "microRNAs in colon cancer: A roadmap for discovery", FEBS Letters, 586(19), pp.3000~3007 (2012), Wiley[DOI]
- Pan Q, "Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing", Carcinogenesis, 41, pp.18~24 (2020)[DOI]
- Claudia Rubie, "Chemokine receptor CCR6 expression is regulated by miR-518a-5p in colorectal cancer cells", Journal of Translational Medicine, 12(1), pp.48~ (2014), Springer Science and Business Media LLC[DOI]
- Lili Ren, "miR-519regulates the proliferation of breast cancer cells via targeting human antigen R", Oncology Letters, 19, pp.1567~1576 (2019), Spandidos Publications[DOI]
- Huan Guo, "Plasma miR-1273g-3p acts as a potential biomarker for early Breast Ductal Cancer diagnosis", Anais da Academia Brasileira de Ciências, 92(1), pp.e20181203~ (2020), FapUNIFESP (SciELO)[DOI]
- Yang Sun, "RELA promotes hypoxia‐induced angiogenesis in human umbilical vascular endothelial cells via LINC01693", miR‐302d, Journal of Cellular Biochemistry, pp.2019, 120(8)[DOI]
